Pfizer Makes Renewed AstraZeneca Approach

Pfizer confirmed it made a renewed approach to AstraZeneca regarding a takeover valued at nearly $100 billion, but the U.K.-listed pharmaceutical firm had declined to engage in talks.



from WSJ.com: US Business http://ift.tt/1kbBPa4

via IFTTT